{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:34:38Z","timestamp":1786739678439,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chronic kidney disease is one of the major global health problems. Chronic renal failure is stimulated by many cytokines and chemokines. Adropin and spexin (SPX) are peptides hormones. These peptides could affect inflammatory conditions, but this is unclear. Due to the limited information, we planned to investigate the impact of adropin and SPX hormones on systemic inflammation in adenine induced chronic kidney failure rat model. Chronic kidney failure was induced by administering adenine hemisulfate. Renal functions were measured by an autoanalyzer. Granulocyte colony-stimulating factor (G-CSF), interferon-gamma (IFN-\u03b3), interleukin (IL)-1\u03b2, IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IL-17A, tumor necrosis factor-alpha, Eotaxin, growth-regulated oncogene-alpha, IP-10, monocyte chemoattractant protein (MCP)-1, MCP-3, macrophage inflammatory protein (MIP)-1\u03b1, MIP-2, and RANTES levels were determined by Luminex. We observed an increase in 24-h urine volume and serum creatinine. Blood urea nitrogen (BUN) and urine protein levels were also significantly higher in the chronic kidney failure (CKF) group. Urine protein and 24-h urine volume were reduced with adropin and SPX treatments. Furthermore, G-CSF, IFN-\u03b3, IL-4, IL-5, IL-10, IL-12, IL-17A, and GRO-\u03b1 significantly increased by CKF induction; however, these cytokines and chemokines significantly decreased by adropin treatment in the CKF group. Furthermore, adropin increased IP-10, MCP-1, MIP-1\u03b1, and MIP-2 levels. In addition, SPX treatment had a more limited effect, decreasing only G-CSF, IFN-\u03b3, and IL-5 levels. The combined adropin + SPX treatment significantly reduced G-CSF, IFN-\u03b3, IL-4, IL-5, IL-12, and IL-17A. Furthermore, IP-10, MCP-1, MCP-3, and MIP-2 were significantly increased by these combined treatments. Our findings indicate that renal functions and inflammatory response were modulated by adropin and SPX peptides. These peptides may have protective effects on systemic inflammation and renal failure progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/cjp.cjp_13_21","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:29:35Z","timestamp":1629181775000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Adropin and Spexin Hormones Regulate the Systemic Inflammation in Adenine-Induced Chronic Kidney Failure in Rat"],"prefix":"10.4103","volume":"64","author":[{"given":"Gulsun","family":"Memi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Yazgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240830","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","article-title":"Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy","volume":"390","author":"Levin","year":"2017","journal-title":"Lancet"},{"key":"R2-4-20240830","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/ndt\/gfy175","article-title":"Chronic inflammation in end-stage renal disease and dialysis","volume":"33","author":"Cobo","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R3-4-20240830","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease","volume":"24","author":"Silverstein","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R4-4-20240830","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R5-4-20240830","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"R6-4-20240830","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-4-20240830","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-016-0559-z","article-title":"The IL-1 cytokine family and its role in inflammation and fibrosis in the lung","volume":"38","author":"Borthwick","year":"2016","journal-title":"Semin Immunopathol"},{"key":"R8-4-20240830","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1101\/gr.5755407","article-title":"Identification of novel peptide hormones in the human proteome by hidden Markov model screening","volume":"17","author":"Mirabeau","year":"2007","journal-title":"Genome Res"},{"key":"R9-4-20240830","doi-asserted-by":"crossref","first-page":"e1000258","DOI":"10.1371\/journal.pcbi.1000258","article-title":"Evolutionary sequence modeling for discovery of peptide hormones","volume":"5","author":"Sonmez","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"R10-4-20240830","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.peptides.2015.07.018","article-title":"Spexin peptide is expressed in human endocrine and epithelial tissues and reduced after glucose load in type 2 diabetes","volume":"71","author":"Gu","year":"2015","journal-title":"Peptides"},{"key":"R11-4-20240830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00210-019-01708-0","article-title":"Spexin protects cardiomyocytes from hypoxia-induced metabolic and mitochondrial dysfunction","volume":"393","author":"Liu","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R12-4-20240830","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1096\/fj.11-192831","article-title":"Peptides derived from the prohormone proNPQ\/spexin are potent central modulators of cardiovascular and renal function and nociception","volume":"26","author":"Toll","year":"2012","journal-title":"FASEB J"},{"key":"R13-4-20240830","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/oby.20725","article-title":"Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet-induced obesity","volume":"22","author":"Walewski","year":"2014","journal-title":"Obesity"},{"key":"R14-4-20240830","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygcen.2018.01.015","article-title":"Spexin as a neuroendocrine signal with emerging functions","volume":"265","author":"Ma","year":"2018","journal-title":"Gen Comp Endocrinol"},{"key":"R15-4-20240830","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fphar.2019.00457","article-title":"Emerging roles of NPQ\/spexin in physiology and pathology","volume":"10","author":"Lv","year":"2019","journal-title":"Front Pharmacol"},{"key":"R16-4-20240830","doi-asserted-by":"crossref","first-page":"158700","DOI":"10.1016\/j.bbalip.2020.158700","article-title":"\u201cSpexin improves adipose tissue inflammation and macrophage recruitment in obese mice\u201d","volume":"1865","author":"Gambaro","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"R17-4-20240830","first-page":"1","article-title":"Effect of spexin on renal dysfunction in experimentally obese rats: Potential mitigating mechanisms via galanin receptor-2","volume":"25","author":"El-Saka","year":"2021","journal-title":"Arch Physiol"},{"key":"R18-4-20240830","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","article-title":"Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism","volume":"8","author":"Kumar","year":"2008","journal-title":"Cell Metab"},{"key":"R19-4-20240830","first-page":"3947806","article-title":"A review of adropin as the medium of dialogue between energy regulation and immune regulation","volume":"2020","author":"Zhang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R20-4-20240830","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2012.31","article-title":"Adropin deficiency is associated with increased adiposity and insulin resistance","volume":"20","author":"Ganesh Kumar","year":"2012","journal-title":"Obesity (Silver Spring"},{"key":"R21-4-20240830","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11010-013-1660-4","article-title":"Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes","volume":"380","author":"Aydin","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"R22-4-20240830","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/molecules25030549","article-title":"Adropin as a fat-burning hormone with multiple functions-review of a decade of research","volume":"27","author":"Jasaszwili","year":"2020","journal-title":"Molecules"},{"key":"R23-4-20240830","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.17219\/acem\/104551","article-title":"Adropin and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease","volume":"28","author":"Maciorkowska","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"R24-4-20240830","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.peptides.2014.03.021","article-title":"Three new players in energy regulation: Preptin, adropin and irisin","volume":"56","author":"Aydin","year":"2014","journal-title":"Peptides"},{"key":"R25-4-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2019.06.005","article-title":"Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency","volume":"98","author":"Altamimi","year":"2019","journal-title":"Metabolism"},{"key":"R26-4-20240830","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2169\/internalmedicine.50.5163","article-title":"Elevated plasma levels of adropin in heart failure patients","volume":"50","author":"Lian","year":"2011","journal-title":"Intern Med"},{"key":"R27-4-20240830","first-page":"100","article-title":"Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats","volume":"117","author":"Akcilar","year":"2016","journal-title":"Bratisl Lek Listy"},{"key":"R28-4-20240830","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3390\/ijms19051293","article-title":"Adropin contributes to anti-atherosclerosis by suppressing monocyte-endothelial cell adhesion and smooth muscle cell proliferation","volume":"19","author":"Sato","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R29-4-20240830","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12574-016-0300-x","article-title":"The effect of chronic renal failure on cardiac function: An experimental study with a rat model","volume":"14","author":"Nakano","year":"2016","journal-title":"J Echocardiogr"},{"key":"R30-4-20240830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nep.13180","article-title":"Adenine-induced chronic kidney disease in rats","volume":"23","author":"Diwan","year":"2018","journal-title":"Nephrology"},{"key":"R31-4-20240830","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbadis.2019.01.024","article-title":"Chronic kidney disease induced by an adenine rich diet upregulates integrin linked kinase (ILK) and its depletion prevents the disease progression","volume":"1865","author":"de Frutos","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R32-4-20240830","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000495750","article-title":"A novel model of chronic kidney disease in rats: Dietary adenine in combination with unilateral nephrectomy","volume":"5","author":"Mu\u00f1oz Abell\u00e1n","year":"2019","journal-title":"Kidney Dis (Basel"},{"key":"R33-4-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10157-008-0119-5","article-title":"Chemokine\/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease","volume":"13","author":"Furuichi","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"R34-4-20240830","doi-asserted-by":"crossref","first-page":"F385","DOI":"10.1152\/ajprenal.00462.2016","article-title":"IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: Compensatory role of natural killer cells in athymic rats","volume":"312","author":"Mehrotra","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"R35-4-20240830","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00467-017-3774-5","article-title":"A review of the role of immune cells in acute kidney injury","volume":"33","author":"Bonavia","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R36-4-20240830","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.2007090982","article-title":"TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity","volume":"19","author":"Zhang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R37-4-20240830","doi-asserted-by":"crossref","first-page":"418185","DOI":"10.1155\/2014\/418185","article-title":"Roles of chronic low-grade inflammation in the development of ectopic fat deposition","volume":"2014","author":"Liu","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R38-4-20240830","first-page":"19","article-title":"Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients","volume":"98","author":"Morita","year":"1997","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"R39-4-20240830","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1210\/jc.2002-021437","article-title":"Association of low interleukin-10 levels with the metabolic syndrome in obese women","volume":"88","author":"Esposito","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-4-20240830","doi-asserted-by":"crossref","first-page":"H1555","DOI":"10.1152\/ajpheart.2000.279.4.H1555","article-title":"IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation","volume":"279","author":"Gunnett","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R41-4-20240830","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.jnen.0000179196.10032.dd","article-title":"G-CSF suppresses edema formation and reduces interleukin-1 beta expression after cerebral ischemia in mice","volume":"64","author":"Gibson","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"R42-4-20240830","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1096\/fj.14-258459","article-title":"Selective delivery of IFN-\u03b3 to renal interstitial myofibroblasts: A novel strategy for the treatment of renal fibrosis","volume":"29","author":"Poosti","year":"2015","journal-title":"FASEB J"},{"key":"R43-4-20240830","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/biomedicines9020182","article-title":"Review on inflammation markers in chronic kidney disease","volume":"11","author":"Petreski","year":"2021","journal-title":"Biomedicines"},{"key":"R44-4-20240830","doi-asserted-by":"crossref","first-page":"a028522","DOI":"10.1101\/cshperspect.a028522","article-title":"Interleukin 17 family cytokines: Signaling mechanisms, biological activities, and therapeutic implications","volume":"10","author":"Monin","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R45-4-20240830","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2016-1177","article-title":"Decreased circulating levels of spexin in obese children","volume":"101","author":"Kumar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-4-20240830","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/ijpo.12249","article-title":"Relationship of circulating spexin with markers of cardiovascular disease: A pilot study in adolescents with obesity","volume":"13","author":"Kumar","year":"2018","journal-title":"Pediatr Obes"},{"key":"R47-4-20240830","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.numecd.2019.11.008","article-title":"Different spexin level in obese vs normal weight children and its relationship with obesity related risk factors","volume":"30","author":"Behrooz","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R48-4-20240830","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s11255-020-02568-x","article-title":"Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients","volume":"52","author":"Li","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"R49-4-20240830","first-page":"250","article-title":"Protective effect of adropin against high fat diet-induced obese diabetic wistar rats via nuclear factor erythroid 2-related factor 2 pathway","volume":"16","author":"Luo","year":"2020","journal-title":"Pharmacogn Mag"},{"key":"R50-4-20240830","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ebiom.2016.05.036","article-title":"Enho mutations causing low adropin: A possible pathomechanism of MPO-ANCA associated lung injury","volume":"9","author":"Gao","year":"2016","journal-title":"EBioMedicine"},{"key":"R51-4-20240830","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3346\/jkms.2007.22.4.611","article-title":"MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease","volume":"22","author":"Joo","year":"2007","journal-title":"J Korean Med Sci"},{"key":"R52-4-20240830","doi-asserted-by":"crossref","first-page":"109","DOI":"10.21608\/0047701","article-title":"Serum adrop\u0131n level and k\u0131dney funct\u0131ons in Type-II diabet\u0131c rat model w\u0131th and w\u0131thout p\u0131ogl\u0131tazone treatment","volume":"47","author":"Ibrahim","year":"2018","journal-title":"Al Azhar Med J"},{"key":"R53-4-20240830","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12668-016-0379-6","article-title":"Cytokine levels in the serum of patients with chronic kidney insufficiency before and after hemodialysis","volume":"7","author":"Romanova","year":"2017","journal-title":"BioNanoScience"},{"key":"R54-4-20240830","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clin.1995.1055","article-title":"T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice","volume":"75","author":"Garlisi","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"R55-4-20240830","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"R56-4-20240830","first-page":"256","article-title":"Serum inflammatory and immune mediators are elevated in early stage diabetic nephropathy","volume":"45","author":"Perlman","year":"2015","journal-title":"Ann Clin Lab Sci"}],"container-title":["Chinese Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/cjp.cjp_13_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:31:14Z","timestamp":1786735874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/cjp.cjp_13_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/cjp.cjp_13_21","relation":{},"ISSN":["0304-4920"],"issn-type":[{"value":"0304-4920","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}